347. Sequence listings.

Where the specification of an application for a patent discloses a nucleotide and/or amino acid sequence, it must include a sequence listing1. Where an applicant has not provided a sequence listing on filing the application2, the comptroller3 may specify a period within which the applicant must provide the sequence listing; and if it is not provided within this period, the comptroller may refuse the application4.

Where a sequence listing is provided after the date of filing the application5, the listing must be accompanied by a declaration that it does not contain matter extending beyond the sequence disclosed in the application